Aurobindo Pharma shares hit 52-week high on US FDA approval for drug to treat infection
Shares of Aurobindo Pharma rose 2% to test a 52-week high of Rs 860.85 on Aug 7 after the company was approved for the drug by the US Food and Drug Administration (FDA). vancomycin hydrochloride injection. At 09:52, Aurobindo Pharma was trading at Rs 859.95, up Rs 18.15, or 2.16% on BSE. The Company’s wholly …
Aurobindo Pharma shares hit 52-week high on US FDA approval for drug to treat infection Read More »